Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness
Authors:
- Ariadne AndroulidakiAAAriadne Androulidaki
- Erini DermitzakiEDErini Dermitzaki
- Maria VenihakiMaria Venihaki
- Effie KaragianniEKEffie Karagianni
- Olga RassouliOROlga Rassouli
- Erini AndreakouEAErini Andreakou
- Christos StournarasCSChristos Stournaras
- Andrew N MargiorisAMAndrew N Margioris
- Christos TsatsanisCTChristos Tsatsanis
Open Access
- 2 June 2009
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 8 (1) , 30
Abstract
Introduction: Cancer cells secrete bioactive peptides that act in an autocrine or paracrine fashion affecting tumor growth and metastasis. Corticotropin-releasing factor (CRF), a hypothalamic neuropeptide that controls the response to stress, has been detected in breast cancer tissues and cell lines. CRF can affect breast cancer cells in an autocrine or paracrine manner via its production from innervating sympathetic neurons or immune cells. Methods: In the present study we report our findings regarding the impact of CRF on breast cancer cell motility and invasiveness. For this purpose we used the MCF7 breast cancer cell line and evaluated the effect of CRF on motility and invasiveness using the wound-healing and boyden-chamber assays. In addition, we measured the effect of CRF on molecules that mediate motility by western blot, immunofluorescence, ELISA and RT-PCR. Results: Our findings show that: 1. CRF transiently inhibited the apoptosis of MCF7 cells. 2. CRF enhanced MCF7 cell motility in a wound healing assay and their invasiveness through extracellular matrix. 3. CRF increased actin polymerization, phosphorylation of Focal Adhesion Kinase (FAK), providing a potential mechanism for the observed induction of MCF7 motility. 4. CRF induced the expression of Cox-1 but not Cox-2 in MCF7 cells as well as the production of prostaglandins, factors known to promote invasiveness and metastasis. Conclusion: Overall, our data suggest that CRF stimulates cell motility and invasiveness of MCF7 cells most probably via induction of FAK phosphorylation and actin filament reorganization and production of prostaglandins via Cox1. Based on these findings we postulate that the stress neuropeptide CRF present in the vicinity of tumors (either produced locally by the tumor cells themselves or by nearby normal cells or secreted from the innervations of surrounding tissues) may play an important role on breast tumor growth and metastatic capacity, providing a potential link between stress and tumor progression.Keywords
This publication has 60 references indexed in Scilit:
- Retracted: TW‐37, a small‐molecule inhibitor of Bcl‐2, inhibits cell growth and invasion in pancreatic cancerInternational Journal of Cancer, 2008
- The actin cytoskeleton in cancer cell motilityClinical & Experimental Metastasis, 2008
- RETRACTED ARTICLE: Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastomaOncogene, 2008
- Lamellipodia and filopodia in metastasis and invasionFEBS Letters, 2008
- Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferationProceedings of the National Academy of Sciences, 2008
- Cell responses regulated by early reorganization of actin cytoskeletonFEBS Letters, 2008
- Expression, binding, and signaling properties of CRF2(a)receptors endogenously expressed in human retinoblastoma Y79 cells: passage‐dependent regulation of functional receptorsJournal of Neurochemistry, 2008
- Corticotropin-releasing factor family and its receptors: Tumor therapeutic targets?Biochemical and Biophysical Research Communications, 2007
- Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulationBritish Journal of Cancer, 2007
- Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancerBritish Journal of Cancer, 2007